One of the initial studies reported by Sikand et al. showed that AR is a direct target of miR-488*, which downregulates AR transcriptional activity, inhibiting the endogenous AR protein in both androgen-dependent and androgen-independent PCa cells. The gene discussed is AR; the disease is posterior cortical atrophy.